MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC

Clinical trial NCT07327021 · RECRUITING

Trial details

NCT number: NCT07327021
Sponsor: Tel-Aviv Sourasky Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

TNBC, Triple Negative Breast Cancer Early Breast Cancer

Start date: 2025-11-11
Primary completion: 2028-02-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.